AI will 'destroy employment in some areas' and boost others, says top Goldman economist
By William Watts
'It will destroy employment in some areas. There will be parts of the labor markets where tasks can be replaced. And to a degree that is going to result in reduced employment there. But then you'll also find other ways of innovating and creating more jobs somewhere else.'Jan Hatzius, chief economist, Goldman Sachs
That's Jan Hatzius, chief economist at Goldman Sachs Group, offering his views on the impact that artificial intelligence will have on the jobs market in an interview with CNN. Goldman Sachs (GS) has previously estimated that AI could lead to the automation of as many as 300 million full-time jobs around the world, CNN noted.
Hatzius told the cable news channel that AI is "very, very likely" to be a productivity enhancer for the economy. Goldman last year upgraded its long-term forecast for U.S. gross domestic product in part due to expectations around productivity.
Determining the likely winners and losers isn't easy, Hatzius said. The fallout is a continuous of a pattern that's held for hundreds of years - with labor-saving innovations reducing employment in some areas and enhancing it in others, he said.
-William Watts
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
03-19-24 1427ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth